Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 44, Issue 6, Pages 1680-1685Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.44.6.1680-1685.2000
Keywords
-
Categories
Funding
- Wellcome Trust Funding Source: Medline
Ask authors/readers for more resources
The therapeutic responses to the eight most widely used antimalarial drugs were assessed in 207 adult patients with Plasmodium vivax malaria. This parasite does not cause marked sequestration, so parasite clearance can be used as a direct measure of antimalarial activity. The activities of these drugs in descending order were artesunate, artemether, chloroquine, mefloquine, quinine, halofantrine, primaquine, and pyrimethamine-sulfadoxine (PS), Therapeutic responses to PS were poor; parasitemias did not clear in 5 of the It PS-treated patients, whereas all the other patients made an initial recovery. Of 166 patients monitored for greater than or equal to 28 days, 35% had reappearance of vivax malaria II to 65 days later and 7% developed falciparum malaria 5 to 21 days after the start of treatment, There were no significant differences in the times taken for vivax malaria reappearance among the different groups except for those given mefloquine and chloroquine, in which all vivax malaria reappearances developed >28 days after treatment, suggesting suppression of the first relapse by these slowly eliminated drugs. There was no evidence of chloroquine resistance. The antimalarial drugs vary considerably in their intrinsic activities and stage specificities of action.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available